ZEMFIRZA Trademark

Trademark Overview


On Tuesday, June 10, 2008, a trademark application was filed for ZEMFIRZA with the United States Patent and Trademark Office. The USPTO has given the ZEMFIRZA trademark a serial number of 77494831. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, February 10, 2017. This trademark is owned by AstraZeneca AB. The ZEMFIRZA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular, gastrointestinal, respiratory and nervous systems; Pharmaceutical preparations for the treatment of pain, inflammation and infection; Pharmaceutical preparations for the treatment of cancer, diabetes, obesity, and psychiatric and neurological diseases and disorders
zemfirza

General Information


Serial Number77494831
Word MarkZEMFIRZA
Filing DateTuesday, June 10, 2008
Status710 - CANCELLED - SECTION 8
Status DateFriday, February 10, 2017
Registration Number3812522
Registration DateTuesday, July 6, 2010
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 20, 2010

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular, gastrointestinal, respiratory and nervous systems; Pharmaceutical preparations for the treatment of pain, inflammation and infection; Pharmaceutical preparations for the treatment of cancer, diabetes, obesity, and psychiatric and neurological diseases and disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, February 10, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAstraZeneca AB
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressSödertälje
SE

Party NameAstraZeneca AB
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressSödertälje
SE

Party NameAstraZeneca AB
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressSödertälje
SE

Trademark Events


Event DateEvent Description
Friday, February 10, 2017CANCELLED SEC. 8 (6-YR)
Tuesday, July 6, 2010REGISTERED-PRINCIPAL REGISTER
Tuesday, April 20, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 20, 2010PUBLISHED FOR OPPOSITION
Monday, March 15, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, March 15, 2010ASSIGNED TO LIE
Saturday, March 13, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, March 8, 2010TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 8, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 8, 2010TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Friday, March 5, 2010TEAS DELETE 1(B) BASIS RECEIVED
Monday, September 7, 2009NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Monday, September 7, 2009INQUIRY TO SUSPENSION E-MAILED
Monday, September 7, 2009SUSPENSION INQUIRY WRITTEN
Sunday, August 23, 2009LIE CHECKED SUSP - TO ATTY FOR ACTION
Sunday, August 23, 2009ASSIGNED TO LIE
Monday, February 23, 2009NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, February 23, 2009LETTER OF SUSPENSION E-MAILED
Monday, February 23, 2009SUSPENSION LETTER WRITTEN
Monday, February 23, 2009EXAMINER'S AMENDMENT ENTERED
Monday, February 23, 2009NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, February 23, 2009EXAMINERS AMENDMENT E-MAILED
Monday, February 23, 2009EXAMINERS AMENDMENT -WRITTEN
Monday, September 15, 2008NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, September 15, 2008NON-FINAL ACTION E-MAILED
Monday, September 15, 2008NON-FINAL ACTION WRITTEN
Saturday, September 13, 2008ASSIGNED TO EXAMINER
Friday, June 13, 2008NEW APPLICATION ENTERED IN TRAM